Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
about
Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF TrialsDirect oral anticoagulants in patients with chronic kidney disease: patient selection and special considerationsOvercoming global challenges in stroke prophylaxis in atrial fibrillation: The role of non-vitamin K antagonist oral anticoagulants.Thromboembolic and bleeding risks in patients undergoing atrial fibrillation ablation: oral anticoagulation perspectives.Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation.Anti-thrombotic therapy for atrial fibrillation in patients with chronic kidney disease: Current views.
P2860
Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Management of atrial fibrillat ...... art Rhythm Association Survey.
@en
type
label
Management of atrial fibrillat ...... art Rhythm Association Survey.
@en
prefLabel
Management of atrial fibrillat ...... art Rhythm Association Survey.
@en
P2093
P2860
P356
P1433
P1476
Management of atrial fibrillat ...... art Rhythm Association Survey.
@en
P2093
Conducted by the Scientific Initiatives Committee, European Heart Rhythm Association
Jean-Claude Deharo
Radoslaw Lenarczyk
Tatjana S Potpara
Torben B Larsen
P2860
P304
P356
10.1093/EUROPACE/EUV416
P577
2015-12-01T00:00:00Z